NCT01208454 2015-11-24Vorinostat and Isotretinoin in Treating Patients With High-Risk Refractory or Recurrent NeuroblastomaNational Cancer Institute (NCI)Phase 1 Completed29 enrolled
NCT00217412 2014-06-17Vorinostat With or Without Isotretinoin in Treating Young Patients With Recurrent or Refractory Solid Tumors, Lymphoma, or LeukemiaNational Cancer Institute (NCI)Phase 1 Completed60 enrolled